Validating a method you did not develop — does this still hold? posts 121–149

Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the method name.

Scoping that to what I have actually seen rather than what I have read.

The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.

Adding the measurement that post #122 says would settle it.

Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.

Worth checking against a second source before it gets quoted onward.

Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with its own degradation products has not answered it.

A guess, clearly labelled as one.

The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.

I had written a reply contradicting post #124 and deleted it. Here is what survived.

A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method stability-indicating without that work is a claim rather than a property.

Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures of compounds, and degraded samples.

That is all the detail I have. Someone else will have more.

Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.

Someone will know this better than I do and I hope they say so.

Taking post #126 at face value and following it one step further.

The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.

An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods' demonstrated precision.

I am describing what is, rather than arguing for what should be.

Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part of validation that predicts whether a method will transfer.

Reading rather than answering, but this is the post I would point somebody at.

On post #131 — agreed on the reasoning, with one qualification.

A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many between-laboratory disagreements originate.

It cost nothing to check and would have cost something not to.

Picking up post #131: that is the part I would want checked first.

Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can separate them from the parent peak. Acceptance is that the method is stability-indicating.

Stating my assumptions rather than smuggling them in.